with a proven record of experience.
Atsushi, our President, has more than 25 years of experience in the pharmaceutical industry.
Atsushi has been an integral member of Mitsubishi Tanabe Pharma America (MTPA) since its inception in 2009. Prior to his current role, he was Vice President of Corporate Strategy and Operations at Mitsubishi Tanabe Pharma Holdings America. From 2012 to 2014, Atsushi served as Group Manager for US/EU Operations of the International Department for Mitsubishi Tanabe Pharma Corporation. He also worked at MTPA as Director of Corporate Strategy and Marketing from 2008 to 2012. Prior to this, Atsushi was a Manager at Mitsubishi Tanabe Pharma Company.
Atsushi holds a Bachelor of Agriculture from Hiroshima University, and a Master of Science in Management of Technology from Massachusetts Institute of Technology.
VP, Chief Commercial Officer
As our Vice President, Chief Commercial Officer, Tom brings more than 25 years of commercial leadership experience in the biopharmaceutical industry.
Before joining us in March 2016, Tom served as the Vice President of Marketing, Sales, and Commercial Operations for Marathon Pharmaceuticals, a startup company specializing in orphan drugs and rare diseases. Prior to this, Tom worked as Vice President at Boehringer Ingelheim, where he built a highly successful hospital sales team. From 2003 to 2010, Tom was a Sales Director for Johnson Johnson, where he reshaped the company s strategic approach and earned the Johnson Johnson Global Standards of Leadership Award. During his 18-year tenure at Abbott, Tom launched products across various therapeutic categories, including infectious diseases, CNS, and immunology.
Tom has a Bachelor of Science in Biochemistry from Northern Michigan University.
Jean Hubble, MD
Jean serves as our Vice President, Medical Affairs. She has dedicated much of her career to Parkinson s disease, neurodegenerative research, and the advancement of patient care.
Before joining us, Jean was Senior Medical Director at US WorldMeds from 2012 to 2016. She also held roles in US Medical Affairs, Global Medical Affairs, and Drug Development at Ipsen Biopharmaceuticals, Boehringer Ingelheim, Vernalis, and Johnson Johnson. Jean began her career in the pharmaceutical industry when she joined the neuroscience team at Novartis in 2002, overseeing an investigational drug program for the treatment of amyotrophic lateral sclerosis and Parkinson s disease. Prior to this, she was a tenured associate professor of neurology at the Ohio State University.
Jean has a medical degree from the University of Kansas, and completed her clinical training in neurology at the Ohio State University Medical Center.
Armand joined Mitsubishi Tanabe Pharma America as our Vice President of Operations and Strategy in 2016. He has more than 25 years of experience in pharmaceutical leadership roles in sales, marketing, business operations, and strategic planning.
Prior to his current role, Armand spent 8 years as Executive Director, Marketing Access and Planning at Mitsubishi Tanabe Holdings America. From 2003 to 2008, he served as Director at Pfizer. He also launched multiple products in the biologic and biotech market segments at Alpha Therapeutic Corporation from 1998 to 2003, and at Bayer, where he started in 1984.
Armand has a Bachelor of Science in Business Administration from Bryant University, and an MBA in E-Commerce from Jones International University.
As our Vice President of Market Access, Kevin brings more than 30 years of commercial experience in the pharmaceutical and medical device industry, having served in a wide range of roles ranging from field sales to executive leadership.
Most recently, Kevin served as the Vice President of Market Access at Bioventus, where he was responsible for leading payer, trade, marketing, contracting, work compensation, and government teams. Prior to that, Kevin spent 6 years at Endo Pharmaceuticals, culminating in the role of Senior Director of Managed Markets. Earlier in his career, Kevin held roles in managed markets and sales at a number of pharmaceutical companies.
Kevin holds a Bachelor of Science in Forest Biology and Ichthyology from the State University of New York.